Recombinant Human Transmembrane protein 169 (TMEM169)

What is the genomic organization of the TMEM169 gene?

The TMEM169 gene spans 20,918 bases (216,081,866-216,102,783) on the positive strand of chromosome 2q35 and contains four exons . The gene's promoter (GXP_6745619) is 1242 base pairs at coordinates 216080866-216082107 . The TMEM169 gene produces five alternatively spliced variants generating four transcript variants, though all encode the same protein . The direct neighboring genes include XRCC5 (X-ray repair cross complementing 5) and PECR (peroxisomal trans-2-enoyl-CoA reductase) .

How is TMEM169 expressed in different tissues and developmental stages?

TMEM169 shows highest expression in the brain, particularly in the fetal brain, suggesting its importance during neurodevelopment . This expression pattern correlates with its proposed function in neuronal development and synapse formation. The strong expression in fetal brain tissue highlights its potential role in early brain development processes, which aligns with findings that link TMEM169 dysfunction to neurodevelopmental disorders like autism spectrum disorder .

How evolutionarily conserved is TMEM169 across species?

TMEM169 demonstrates significant evolutionary conservation across diverse taxonomic groups, with homologs identified in mammals, reptiles, amphibians, birds, fish, chordates, and invertebrates . The gene has been specifically identified in the Cape elephant shrew (Elephantulus edwardii) , and the most distantly related homolog has been found in Anopheles albimanus (a mosquito species) . This high degree of conservation suggests TMEM169 likely serves a fundamental biological function that has been maintained throughout evolution.

What experimental methodologies are commonly used to study TMEM169?

Various experimental approaches can be employed to study TMEM169, including:

What is the proposed function of TMEM169 in neuronal development?

Recent research indicates that TMEM169 plays a crucial role in neuronal development and synaptic function. Studies demonstrate that TMEM169 promotes neuronal process and synapse development primarily through its interaction with Shank3, a key scaffolding protein at synapses . Deletion of Tmem169 in the mouse dorsal forebrain results in neuronal morphological abnormalities and synaptic dysfunction . The high expression of TMEM169 in the fetal brain further supports its developmental role .

The protein appears to be involved in critical neurodevelopmental processes including:

• Neuronal morphology regulation

• Synapse formation and maintenance

• Potential roles in neuronal circuit establishment

These functions appear to be mediated through protein-protein interactions with established synaptic proteins, particularly Shank3, which is known to be involved in organizing the postsynaptic density .

What is the relationship between TMEM169 and neurodevelopmental disorders?

TMEM169 has emerging connections to neurodevelopmental disorders, particularly autism spectrum disorder (ASD). Variations on chromosome 2q, where TMEM169 is located (2q35), have been linked to autism, though specific genes responsible had not been previously characterized . Recent research demonstrates that Tmem169-deficient mice display behavioral traits resembling those observed in individuals with autism, regardless of sex .

The molecular pathway connecting TMEM169 to neurodevelopmental disorders appears to involve its interaction with Shank3, a well-established autism risk gene . This interaction suggests a mechanistic link between TMEM169 dysfunction and autism pathophysiology, as Shank3 is crucial for proper synapse development and function.

The study published in February 2025 represents the first characterization of TMEM169 in this context, identifying it as a previously uncharacterized gene that may contribute to autism etiology .

How can researchers effectively express and purify recombinant TMEM169?

Expressing and purifying transmembrane proteins like TMEM169 presents several technical challenges. Based on approaches used for similar transmembrane proteins:

For purification, consider:

• Detergent selection is critical - mild non-ionic detergents (DDM, LMNG) often preserve structure

• Two-step purification typically required (affinity chromatography followed by size exclusion)

• Protein quality assessment through thermal stability assays and circular dichroism

• Consider native lipid nanodiscs for maintaining native environment

When designing constructs, the cytoplasmic domains (N and C termini) offer potential fusion points that may be less disruptive to protein structure than modifications to the transmembrane regions .

What approaches are optimal for studying TMEM169 transmembrane domain interactions?

Studying transmembrane domain (TMD) interactions of proteins like TMEM169 requires specialized techniques. Based on established methodology:

The ToxR assay represents an effective approach for investigating TMEM169 TMD interactions. This technique has been successfully applied to determine interfaces of various self-interacting TMDs . In this assay, the TMD of interest is fused to the ToxR transcription activator and MalE domains, allowing for measurement of TMD-TMD interactions through reporter gene expression .

For comprehensive characterization, scanning mutagenesis should be performed by systematically substituting residues within the TMD with alanine or isoleucine. This approach can identify specific residues critical for TMD-TMD interactions . Research demonstrates that interfacial residues of homotypic TMD-TMD interfaces tend to be more conserved, coevolved, and polar than non-interfacial residues . Additionally, interface positions are typically deficient in β-branched residues and often contain GxxxG motifs .

Other complementary methods include:

• FRET-based approaches for measuring proximity between labeled TMDs

• Cross-linking studies for capturing transient interactions

• NMR spectroscopy for atomic-level resolution

• Molecular dynamics simulations for computational insights

How does TMEM169 interact with Shank3 and other neuronal proteins?

TMEM169 has been demonstrated to interact with Shank3, a key scaffolding protein at excitatory synapses . This interaction appears to be crucial for TMEM169's role in promoting neuronal process and synapse development . The finding that TMEM169 interacts with Shank3 is particularly significant because Shank3 is a well-established autism risk gene, providing a molecular link between TMEM169 and neurodevelopmental disorders.

While the specific binding domains and interaction mechanisms are still being characterized, the functional consequences of this interaction include:

• Promotion of neuronal process development

• Enhancement of synapse formation

• Potential modulation of synaptic signaling pathways

Research also indicates that TMEM169 interacts with several other key neuronal proteins implicated in neurodevelopmental diseases , though these additional partners require further investigation. Understanding these protein-protein interactions is crucial for elucidating TMEM169's functions in neuronal development and synaptic regulation.

What are the best experimental models for studying TMEM169 function?

For studying TMEM169 function, researchers should consider different model systems based on specific research questions:

Recent research has primarily utilized mouse models with cortex-specific Tmem169 deficiency, which have proven valuable for investigating the role of TMEM169 in neuronal development and function . These conditional knockout strategies targeting the dorsal forebrain have allowed researchers to observe neuronal morphological abnormalities and synaptic dysfunction resulting from Tmem169 deletion .

What considerations are important when designing antibodies against TMEM169?

Designing effective antibodies against transmembrane proteins like TMEM169 requires careful consideration of several factors:

• Epitope Selection:

  • Prioritize cytoplasmic domains (N and C termini) which are more accessible and less hydrophobic

  • Avoid transmembrane domains (amino acids 160-180 and 211-231) as they are typically embedded in the membrane

  • Consider peptide regions with high predicted antigenicity and surface exposure

• Antibody Format Considerations:

  • Monoclonal antibodies: Higher specificity but more resource-intensive to develop

  • Polyclonal antibodies: Broader epitope recognition but potential for cross-reactivity

  • Recombinant antibodies: Consistent production and potential for engineering

• Validation Strategies:

  • Use knockout/knockdown models as negative controls

  • Perform peptide competition assays to confirm specificity

  • Validate across multiple applications (WB, IF, IP) if intended for diverse uses

  • Test in both overexpression systems and with endogenous protein

• Special Considerations for TMEM169:

  • Given its high expression in brain tissue, validate in neural preparations

  • Consider cross-reactivity with other transmembrane proteins, particularly those with similar topologies

  • Test fixation and permeabilization protocols carefully for immunofluorescence applications

How can CRISPR/Cas9 be optimized for TMEM169 gene editing in experimental models?

Optimizing CRISPR/Cas9 for TMEM169 gene editing requires careful consideration of several technical aspects:

• Guide RNA Design:

  • Target early exons (particularly exons 1-2) to ensure functional knockout

  • Consider targeting regions encoding functional domains (transmembrane domains at aa 160-180 or 211-231)

  • Evaluate off-target potential using prediction algorithms

  • Design multiple guide RNAs and validate cutting efficiency

• Delivery Methods for Neuronal Applications:

  Delivery Method	Advantages	Limitations	TMEM169-Specific Considerations
  AAV vectors	Efficient neuronal transduction, can target specific brain regions	Limited cargo capacity	May require split-Cas9 approach due to size
  Lentiviral vectors	Larger cargo capacity, stable integration	Safety concerns, more random targeting	Good for in vitro neuronal studies
  Electroporation	Effective for neural progenitors	Limited to accessible cell populations	Useful for embryonic manipulations
  Lipid nanoparticles	Reduced immunogenicity, non-viral	Lower efficiency in neurons	May require neuronal targeting moieties

• Validation Approaches:

  • Genomic: T7E1 assay, sequencing of target region

  • Transcriptomic: RT-PCR across edited region, RNA-seq

  • Protein: Western blot (if antibodies available)

  • Functional: Assess interaction with Shank3, examine neuronal morphology

• Temporal Considerations:

  • Given TMEM169's high expression in fetal brain, developmental timing of editing is crucial

  • Consider inducible systems for temporal control of gene editing

What methodologies are most effective for visualizing TMEM169 subcellular localization?

Visualizing TMEM169 subcellular localization requires techniques optimized for membrane proteins:

• Fluorescent Protein Tagging:

  • Position tags at cytoplasmic N or C terminus to minimize interference with transmembrane domains

  • Validate that fusion proteins maintain normal protein interactions (e.g., with Shank3)

  • Consider smaller fluorescent proteins (mNeonGreen, mEOS) to minimize functional disruption

  • Use both C and N-terminal fusions to confirm localization patterns

• Advanced Microscopy Techniques:

  Technique	Resolution	Applications for TMEM169
  Confocal microscopy	~200nm	Colocalization with synaptic markers
  STED super-resolution	~30-70nm	Precise membrane localization, clustering analysis
  PALM/STORM	~10-30nm	Single-molecule organization at synapses
  Expansion microscopy	Physical expansion	Visualization within complex neuronal structures

• Co-localization Analysis:

  • Synaptic markers: PSD-95, Bassoon, Synaptophysin

  • Membrane compartment markers: Early/late endosomes, ER, Golgi

  • TMEM169 interaction partners: Shank3 and other identified binding partners

• Live-Cell Imaging Considerations:

  • Photobleaching approaches (FRAP) to assess protein mobility

  • Pulse-chase strategies to track protein trafficking

  • Time-lapse imaging during neuronal development to correlate with morphological changes

How can researchers investigate the role of TMEM169 in synaptic function?

Investigating TMEM169's role in synaptic function requires a multi-faceted approach combining molecular, cellular, and functional techniques:

• Electrophysiological Approaches:

  • Whole-cell patch clamp recording to measure synaptic transmission in TMEM169-deficient neurons

  • Analysis of miniature excitatory postsynaptic currents (mEPSCs) to assess spontaneous synaptic activity

  • Paired recordings to evaluate specific synaptic connections

  • Field recordings to assess network-level effects

• Molecular and Biochemical Analysis:

  • Co-immunoprecipitation to confirm and characterize Shank3 interaction in synaptic fractions

  • Synaptosome isolation to assess TMEM169 enrichment at synapses

  • Proximity labeling (BioID, APEX) to identify synaptic protein neighbors

  • Quantification of synaptic protein levels in TMEM169-deficient conditions

• Imaging-Based Functional Analysis:

  Approach	Application	Technical Considerations
  Calcium imaging	Activity-dependent calcium dynamics	Use GCaMP in TMEM169 WT vs. KO neurons
  FM dye uptake/release	Synaptic vesicle cycling	Assess presynaptic function
  pH-sensitive reporters	Vesicle fusion and recycling	SypHy or pHluorin-based assays
  Live imaging of synaptic proteins	Recruitment dynamics	Fluorescently tagged PSD proteins

• Synapse Quantification:

  • Density of excitatory and inhibitory synapses in TMEM169-deficient neurons

  • Morphological classification of dendritic spines

  • Ultrastructural analysis using electron microscopy

  • Super-resolution analysis of synaptic protein organization

• Behavioral Correlates:

  • Learning and memory tasks in conditional knockout models

  • Social interaction paradigms relevant to autism-like phenotypes

  • Analysis of repetitive behaviors

  • Sensory processing and integration assessment